Hims and her

Hims & Hers (Hims) shares fell nearly 35% on Monday after Novo Nordisk (NVO) announced that it was completing the cooperation to make its weakened blockbuster medicine, Wegov, available on the Hims Tele leaf. Novo Nordisk said Hims & Her violates the law by continuing to sell Copycat semaglutide, the key ingredient in Wegovy, along … Read more

Hims & Hers (Hims) shares fell about 30% in early trade on Monday after Novo Nordisk (NVO) announced that it ended the cooperation to make its weakening drug, Wegovy, available on the Hims Hims platform. Novo Nordisk said Hims & Her violates the law by continuing to sell Copycat semaglutide, the key ingredient in Wegovy, … Read more